Kishimoto Takashi Kei
- SEC CIK
- 0001676930
No open-market purchases or sales filed in the past year.
Current role at each company
- RNAC Cartesian Therapeutics, Inc.Chief Scientific Officeras of Jun 1, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Kishimoto Takashi Kei as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 6, 2023 (view filing) | Jan 4-5 | 2 days | Kishimoto Takashi KeiChief Scientific Officer | SSale | −9.78K | $1.13 | −$11.1K | −2.6%364.3K after | 4 lots |
| Jan 7, 2022 (view filing) | Jan 5 | 2 days | Kishimoto Takashi KeiChief Scientific Officer | SSale | −3.42K | $3.09 | −$10.6K | −1.3%268.4K after | |
| Dec 14, 2021 (view filing) | Dec 10 | 4 days | Kishimoto Takashi KeiChief Scientific Officer | SSale | −4.37K | $2.99 | −$13.1K | −2.1%199.8K after | |
| Oct 15, 2021 (view filing) | Oct 13 | 2 days | Kishimoto Takashi KeiChief Scientific Officer | SSale | −3.89K | $4.39 | −$17.1K | −2.0%190.4K after |